Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page
- Check2 days agoChange DetectedThe page adds recruitment status indicating no participants are being sought and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study), while adjusting the Intervention/Treatment header formatting and updating the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check9 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a minor update to the page. This change does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedStatus updated to Active, not recruiting, with enrollment reported as 107 and primary completion set for 2026-12. The principal investigator's contact information was removed from the page.SummaryDifference1%

- Check30 days agoChange DetectedThe page revision has been updated to v3.5.4, indicating a backend or rendering system update. No changes to the displayed study information are introduced.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a non-content site release.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.